Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorKEMP, Steven A.
dc.contributor.authorCHARLES, Oscar J.
dc.contributor.authorDERACHE, Anne
dc.contributor.authorSMIDT, Werner
dc.contributor.authorMARTIN, Darren P.
dc.contributor.authorIWUJI, Collins
dc.contributor.authorADAMSON, John
dc.contributor.authorGOVENDER, Katya
dc.contributor.authorDE OLIVEIRA, Tulio
hal.structure.identifierBordeaux population health [BPH]
hal.structure.identifierGlobal Health in the Global South [GHiGS]
dc.contributor.authorDABIS, Francois
dc.contributor.authorPILLAY, Deenan
dc.contributor.authorGOLDSTEIN, Richard A.
dc.contributor.authorGUPTA, Ravindra K.
dc.date.accessioned2022-05-11T13:52:21Z
dc.date.available2022-05-11T13:52:21Z
dc.date.issued2022-04-21
dc.identifier.issn2150-7511 (Electronic)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/140040
dc.description.abstractEnProlonged virologic failure on 2nd-line protease inhibitor (PI)-based antiretroviral therapy (ART) without emergence of major protease mutations is well recognized and provides an opportunity to study within-host evolution in long-term viremic individuals. Using next-generation sequencing and in silico haplotype reconstruction, we analyzed whole-genome sequences from longitudinal plasma samples of eight chronically infected HIV-1-positive individuals failing 2nd-line regimens from the French National Agency for AIDS and Viral Hepatitis Research (ANRS) 12249 Treatment as Prevention (TasP) trial. On nonsuppressive ART, there were large fluctuations in synonymous and nonsynonymous variant frequencies despite stable viremia. Reconstructed haplotypes provided evidence for selective sweeps during periods of partial adherence, and viral haplotype competition, during periods of low drug exposure. Drug resistance mutations in reverse transcriptase (RT) were used as markers of viral haplotypes in the reservoir, and their distribution over time indicated recombination. We independently observed linkage disequilibrium decay, indicative of recombination. These data highlight dramatic changes in virus population structure that occur during stable viremia under nonsuppressive ART. IMPORTANCE HIV-1 infections are most commonly initiated with a single founder virus and are characterized by extensive inter- and intraparticipant genetic diversity. However, existing literature on HIV-1 intrahost population dynamics is largely limited to untreated infections, predominantly in subtype B-infected individuals. The manuscript characterizes viral population dynamics in long-term viremic treatment-experienced individuals, which has not been previously characterized. These data are particularly relevant for understanding HIV dynamics but can also be applied to other RNA viruses. With this unique data set we propose that the virus is highly unstable, and we have found compelling evidence of HIV-1 within-host viral diversification, recombination, and haplotype competition during nonsuppressive ART.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enAntiretroviral resistance
dc.subject.enClinical failure
dc.subject.enDrug resistance evolution
dc.subject.enHuman immunodeficiency virus
dc.title.enHIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy
dc.typeArticle de revueen_US
dc.identifier.doi10.1128/mbio.00269-22en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed35446121en_US
bordeaux.journalmBioen_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamGHIGS_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAgence Nationale de Recherches sur le Sida et les Hépatites Viralesen_US
bordeaux.identifier.funderIDDeutsche Gesellschaft für Internationale Zusammenarbeiten_US
bordeaux.identifier.funderIDBill and Melinda Gates Foundationen_US
bordeaux.identifier.funderIDWellcome Trusten_US
hal.identifierhal-03665249
hal.version1
hal.date.transferred2022-05-11T13:52:30Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=mBio&rft.date=2022-04-21&rft.eissn=2150-7511%20(Electronic)&rft.issn=2150-7511%20(Electronic)&rft.au=KEMP,%20Steven%20A.&CHARLES,%20Oscar%20J.&DERACHE,%20Anne&SMIDT,%20Werner&MARTIN,%20Darren%20P.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée